Skip to main content
Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0091
+0.0002 (2.25%)
Apr 28, 2026, 9:30 AM EST

Emmaus Life Sciences Revenue

In the year 2025, Emmaus Life Sciences had annual revenue of $12.45M, down -25.22%. Emmaus Life Sciences had revenue of $3.85M in the quarter ending December 31, 2025, with 17.01% growth.

Revenue
12.45M
Revenue Growth
-25.22%
P/S Ratio
0.05
Revenue / Employee
377.36K
Employees
33
Market Cap
638.71K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202512.45M-4.20M-25.22%
Dec 31, 202416.65M-12.94M-43.73%
Dec 31, 202329.60M11.21M60.94%
Dec 31, 202218.39M-2.22M-10.77%
Dec 31, 202120.61M-2.56M-11.04%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SQZ Biotechnologies Company 12.12M
Aibotics 2.18K
Regenerative Medical Technology Group 5.04M
EV Biologics 9.47M
Halberd 6.94K
CNBX Pharmaceuticals 40.64K
Sorrento Therapeutics 64.27M
Revenue Rankings

Emmaus Life Sciences News

More News